The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Real-world studies confirm that pairing LONSURF with bevacizumab increases efficacy in patients with metastatic colorectal cancer </b ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after ...